This paper compared blood stored in PAXgene or Streck cell-free DNA (cfDNA) tubes for plasma volume, DNA yield and fragment size, and detection of spiked-in DNA. The authors also tested the plasma for formaldehyde.
Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.
Voss T, Ullius A, Schönborn M, Oelmüller U
Purpose
Conclusion
The average plasma volume was 41% higher in blood collected and stored in PAXgene tubes than Streck cfDNA tubes, but this difference could be attributed to the difference in stabilizer volume between the two tube types. DNA yield was slightly but not significantly higher in PAXgene than Streck plasma. Interestingly, there was no noticeable difference in DNA quantity or fragment size between specimens spiked with 150 bp fragments of DNA and those with no DNA added. Detection rates of the spiked in DNA mutations were higher in PAXgene plasma than Streck plasma. The amount of DNA necessary to achieve detection in 95% of cases was lower when spiked into blood in PAXgene rather than Streck cfDNA tubes, but the amount needed was dependent on the mutation. Formaldehyde was detected in plasma from the Streck tubes but not PAXgene tubes.
Studies (1)
Purpose
This study compared blood stored in PAXgene or Streck cfDNA tubes for plasma volume, DNA yield and fragment size, and recovery of spiked-in DNA. The authors also tested the plasma for formaldehyde. Blood from 174 blood donors was collected into PAXgene blood ccfDNA tubes and Streck Cell-Free DNA BCT tubes. Within 2 h of blood draw, four of five tubes of blood of each type were spiked with varying amounts of cfDNA-sized fragments (170 bp) of DNA containing EGFR (108 blood donors) and BRAF (66 donors) mutations. Blood was stored for 3 days at room temperature, before isolation of plasma from PAXgene tubes by two sequential centrifugations at 1900 g for 15 min and from Streck tubes by two sequential centrifugations at 1600 g for 10 min. Plasma from the same tube type was pooled, aliquoted and frozen at -20°C. PAXgene plasma was thawed at 30°C and Streck plasma thawed at room temperature before isolation of cfDNA using the QIAamp Circulating Nucleic Acid Kit. cfDNA was quantified using the Qubit 1x dsDNA HS Assay-Kit and fragment size was analyzed using the High Sensitivity DNA Kit on a 2100 Bioanalyzer. Recovery of spiked-in cfDNA was quantified using the real-time PCR-based Therascreen EGFR and BRAF Plasma RGQ PCR Kits. Formaldehyde content of plasma was quantified using Quantofix Formaldehyde strips.
Summary of Findings
The average plasma volume was 41% higher in blood collected and stored in PAXgene tubes than Streck cfDNA tubes (5.5 mL versus 3.9 mL,), but this difference could be attributed to the difference in stabilizer volume between the two tube types. DNA yield was slightly but not significantly higher in PAXgene than Streck plasma (4.4 ± 0.8 ng versus 3.3±0.9 ng). Interestingly, there was no noticeable difference in DNA quantity or fragment size between specimens spiked with 150 bp fragments of DNA and those with no DNA added. Detection rates of the mutations in the spiked-in DNA was higher in PAXgene plasma than Streck plasma. The amount of DNA necessary to achieve detection in 95% of cases was lower when spiked into blood in PAXgene rather than Streck cfDNA tubes (6.1-15.6 ng/mL versus 19.6-49.3 ng/mL), but the amount needed was dependent on the mutation. Formaldehyde was detected in plasma from the Streck tubes but not PAXgene tubes.
Biospecimens
FluidBloodFluidPlasmaPreservation Types
PAXgeneStreck/BCTDiagnoses
NormalNot specifiedPlatforms
Small moleculeClinical chemistry/auto analyzerDNAAutomated electrophoresis/BioanalyzerDNASpectrophotometryDNAReal-time qPCRDNAFluorometryPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Type of collection container/solution PAXgene ccfDNA tubeStreck Cell-Free DNA BCTBiospecimen Preservation Type of fixation/preservation Blood collection tube additivePAXgeneReal-time qPCR Specific Targeted nucleic acid BRAF mutationsEGFR mutations